Clinical Trial Update: S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for AZD2171 (S0509) in malignant pleural mesothelioma unsuitable for surgery; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Mesothelioma
• Malignant Mesothelioma
• Malignant Pleural Mesothelioma
• Sarcomatous Mesothelioma

Drugs mentioned

• AZD2171 (cediranib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Mesothelioma, Epithelial Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2015-10-21